Physician profile
Devon Elder
NPI 1962136044
$7,068.90
in general payments reported to CMS, 2019-2025
39 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,179 · 2023: $3,352 · 2024: $2,097 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,700 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,699.73 |
| Education | $190.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,093.77 | 2022-2024 | Arexvy, Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals Lp | $1,021.99 | 2022-2024 | Fasenra, Airsupra, Tezspire |
| Genzyme Corporation | $784.30 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $597.98 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $472.84 | 2022-2025 | Dupixent, Libtayo |
| Sanofi-Aventis U.S. LLC | $421.24 | 2022-2024 | |
| Csl Behring | $300.34 | 2022-2024 | Hizentra, Haegarda |
| Takeda Pharmaceuticals U.S.A., INC. | $257.64 | 2022-2024 | Cuvitru, Takhzyro, Hyqvia |
| Genentech USA, INC. | $239.88 | 2022-2024 | Xolair |
| Incyte Corporation | $233.23 | 2022-2025 | Opzelura |
| Pharming Healthcare, INC. | $230.24 | 2022-2024 | Ruconest |
| Octapharma USA, INC. | $140.00 | 2022-2024 | Cutaquig, Octagam Immune Globulin (Human), Panzyga |
| Alk-Abello, INC | $123.40 | 2022-2023 | Ragwitek, Odactra, Grastek |
| Kaleo, INC. | $120.71 | 2023-2024 | Auvi-Q |
| Amgen INC. | $103.97 | 2022-2025 | Otezla, Otezla, Tezspire |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.